Christophe Chesné 
Eva-Anne SUBILEAU
Ismaïl Benmosbah 
Estelle Schaefer
Agnès Jamin 
Pierre Daligaux
Biopredic International, a biotechnology SME, markets human and animal cells and tissue models for the development and screening of drugs and other xenobiotics. Biopredic International has a large expertise in tissue sourcing, cell isolation, cell culture, functional control and cell cryopreservation as in vitro tools for studies on drug metabolism and drug toxicity. BPI has been working over the years on the development and the use of hepatocytes as tool for liver metabolism and hepatotoxicology studies. Biopredic is also the exclusive worldwide licensor of HepaRG™, the human hepatic stem cell line.